{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif
AM-CKD Survey Questionnaire
  1. How many CKD patients do you treat in a week? *

  2. What percentage of CKD patients will be male and female? *
    3. Sex % Patients
    Male
    %
    Female
    %
  3. Out of 100 CKD patients, what percentage of patients fall under each of the stage *
    4. Stages of CKD % Patient
    Stage 1
    %
    Stage 2
    %
    Stage 3
    %
    Stage 4
    %
    Stage 5
    %
  4. what % of your CKD patients are on dialysis? *
    5. %
  5. At what stage of the CKD, Patient is put on dialysis? *

  6. % of patients undergo the hemodialysis sessions in a week as per below mentioned timelines *
    7. No of dialysis session % Patients
    Once a week
    %
    Twice a week
    %
    Thrice a week
    %
    More the 3 sessions
    %
  7. What % of CKD patients, suffer with anaemia? *

  8. What is the frequency of tests (HB concentration) to diagnose or screen Iron deficiency in CKD patients? *

  9. What is the frequency of tests to check Iron status in CKD patients? *

  10. What are the goals of Iron supplementation? *

  11. Please select the reasons for IV iron supplementation *

  12. In Patients with iron deficiency with heart failure (HF) and reduced ejection fraction what Iron supplementation will be recommended by you? *

  13. Please provide the patient profile in whom high-dose low frequency IV iron regimen versus low dose IV iron regimen will be preferred *
  14. What is the acceptable ferritin levels with iron supplementation? *

  15. Will you consider iron supplementation in anemia if TSAT and ferritin levels are within normal range? *

  16. How many CKD patients are on Erythropoietin stimulating agents? *
  17. How many patients on Darbepoetin and how many on Erythropoietin? *
    18. Darbepoetin
    Erythropoietin
  18. In which patient profile do you prescribe Erythropoietin and Darbepoetin? *
    19. Patient profile- erythropoietin Patient profile- Darbepoetin

  19. Will you prefer using ESAs and Iron supplementation together? *

  20. Out of 100, What percentage of your patients receive Desidustat, Erythropoietin and Darbepoetin *
    21. Drug % Patient
    Desidustat
    %
    Erythropoietin
    %
    Darbepoetin
    %
  21. Out of 100, What percentage of your Dialysis & non dialysis patients receive Desidustat? *
    22. Dialysis (% Patients) Non- Dialysis (% Patients)
    %
    %
  22. What influences your decision to prescribe Desidustat over other medications? *

  23. Would you consider Desidustat as a first line treatment option for anemia in CKD? *

  24. In which patient profile do you prescribe Desidustat? *
    25. A
    B
    C
  25. In your clinical practice, how long patients continue Desidustat treatment, please provide in % *
    26. Duration % Patient
    > 3 months
    %
    > 6 months
    %
    > 9 months
    %
    > 12 months
    %
  26. What is the haemoglobin target you want to achieve with Desidustat? *

  27. How do you rate the efficacy of Desidustat in managing anaemia compared to ESA? *

  28. What are the primary advantages you observe in using Desidustat for anemia management in CKD patients? (Please tick whichever is appropriate) *
    29. 1 Better Hb control

    2 Fewer adverse effects

    3 Enhanced patient compliance

  29. What further research or evidence would you like to see regarding Desidustat’s efficacy & safety in CKD patients? *

  30. How do you Monitor and evaluate the response of CKD patients to Desidustat treatment? *

  31. How frequently do you ask patients to do the HB test? *

  32. Are there any specific concerns or limitations you encounter when prescribing Desidustat? *

    33. {{--

    --}}
  33. Are you aware of any ongoing clinical trials investigating novel molecules or therapies for Anaemia in CKD patients India? *

  34. Do you believe that there is a need for awareness and education about CKD among common public? *